Current Pharmaceutical Design
Title:Editorial: Natural Products as the Integral Part of the Therapy?
Volume: 23 Issue: 17
Author(s): Maciej Banach*, Dimitri P. Mikhailidis, Maria-Corina Serban and Amirhossein Sahebkar
Affiliation:
- Department of Hypertension WAM University Hospital in Lodz Medical University of Lodz Zeromskiego 113; 90-549 Lodz,Poland
Export Options
About this article
Cite this article as:
Banach Maciej*, Mikhailidis P. Dimitri , Serban Maria-Corina and Sahebkar Amirhossein , Editorial: Natural Products as the Integral Part of the Therapy?, Current Pharmaceutical Design 2017; 23 (17) . https://dx.doi.org/10.2174/1381612823999170404122553
DOI https://dx.doi.org/10.2174/1381612823999170404122553 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Statin Treatment and Carotid Plaque Composition: A Review of Clinical Studies
Current Vascular Pharmacology New Developments in Anti-Platelet Therapies Potential Use of CD39/Vascular ATP Diphosphohydrolase in Thrombotic Disorders
Current Drug Targets Blood Pressure Management in Acute Stroke
Current Hypertension Reviews Aspartic Proteases in Drug Discovery
Current Pharmaceutical Design Review: Metabolism of Immunosuppressant Drugs
Current Drug Metabolism The Role of Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor (AT1-AA) in Pathophysiology of Preeclampsia
Current Pharmaceutical Biotechnology Definition of Postprandial Lipaemia
Current Vascular Pharmacology The Synthesis of Coenzyme Q10
Current Organic Chemistry Evaluation of Common Unfavourable Genetic Variants in Cerebrovascular Diseases: Recommendation for Supportive Genetic Examinations and Methodological Approaches for Common Genetic Variants
Current Medicinal Chemistry Garlic for Cardiovascular Disease: Prevention or Treatment?
Current Pharmaceutical Design Initiation of Dialysis: A Mini-Review of a Changing Paradigm
Cardiovascular & Hematological Disorders-Drug Targets Peri-Procedural Care of Renal Nerve Ablation Candidates
Current Clinical Pharmacology Improved Pharmacokinetic Profile and Anti-Inflammatory Property of a Novel Curcumin Derivative, A50
Letters in Drug Design & Discovery Angiotensin-(1-7): Blood, Heart, and Blood Vessels
Current Medicinal Chemistry - Cardiovascular & Hematological Agents The Innovations in Pulmonary Hypertension Pathophysiology and Treatment: What are our Options!
Current Respiratory Medicine Reviews Vasopressin in Health and Disease with a Focus on Affective Disorders
Central Nervous System Agents in Medicinal Chemistry Inflammation-Induced Thrombosis: Mechanisms, Disease Associations and Management
Current Pharmaceutical Design Gender Disparities in the Prevalence, Awareness, Treatment, and Control of High Blood Pressure
Current Pharmaceutical Design Vascular Wall Responses to Angioplasty and Stenting: Endothelial Injury, Neointimal Hyperplasia and the Process of Restenosis
Vascular Disease Prevention (Discontinued) Beyond Mitochondria, What Would be the Energy Source of the Cell?
Central Nervous System Agents in Medicinal Chemistry